Serina Schama
Physician Assistant · Toledo, OHNPI 1457010175
Payments from drug & device makers
Across 255 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$878
- Vanda Pharmaceuticals Inc.$748
- Lundbeck LLC$600
- AbbVie$592
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$357
- Axsome Therapeutics, Inc.$353
- plus $1K from 8 others
What the payments were for
- Food & beverage$4,69297%
- Education$1603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 45 | $878 |
| Vanda Pharmaceuticals Inc. | 31 | $748 |
| Lundbeck LLC | 28 | $600 |
| AbbVie | 51 | $592 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $357 |
| Axsome Therapeutics, Inc. | 17 | $353 |
| Teva Pharmaceuticals USA, Inc. | 10 | $294 |
| Neurocrine Biosciences, Inc. | 13 | $273 |
| E.r. Squibb & Sons, L.L.C. | 12 | $193 |
| Indivior Inc. | 9 | $189 |
| Supernus Pharmaceuticals, Inc. | 9 | $134 |
| Alkermes, Inc. | 7 | $122 |
| Noven Therapeutics, LLC | 4 | $77 |
| Luye Pharma (USA) Ltd. | 2 | $44 |
How this compares
$4,852 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 32 | $1,978 |
| Buspirone Hcl | 61 | $829 |
| Quetiapine Fumarate | 48 | $811 |
| Oxcarbazepine | 31 | $580 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $389 |
| Venlafaxine Hcl | 11 | $369 |
| Trazodone Hcl | 32 | $345 |
| Paroxetine Hcl | 18 | $213 |
| Alprazolam | 35 | $201 |
| Duloxetine Hcl | 23 | $200 |
| Diazepam | 11 | $193 |
| Mirtazapine | 15 | $173 |
| Clonazepam | 15 | $140 |
| Lithium Carbonate | 20 | $139 |
| Lorazepam | 22 | $115 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Toledo
- Alison FleigToledo$48K
- Ashley SheskeyToledo$20K
- Jessica PalickiToledo$19K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.